000 01306 a2200397 4500
005 20250512132601.0
264 0 _c19690806
008 196908s 0 0 eng d
022 _a0021-129X
040 _aNLM
_beng
_cNLM
100 1 _aO'Brien, E T
245 0 0 _aThe fibrinolytic system in arteriosclerosis.
_h[electronic resource]
260 _bJournal of the Irish Medical Association
_cJun 1969
300 _a203-12 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAge Factors
650 0 4 _aArteriosclerosis
_xdrug therapy
650 0 4 _aBlood Coagulation
650 0 4 _aDiabetes Complications
650 0 4 _aDiet
650 0 4 _aFibrinolysis
650 0 4 _aFibrinolytic Agents
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xtherapeutic use
650 0 4 _aLipids
_xblood
650 0 4 _aObesity
_xphysiopathology
650 0 4 _aPhysical Exertion
650 0 4 _aSex Factors
650 0 4 _aSmoking
650 0 4 _aStress, Psychological
_xphysiopathology
650 0 4 _aThromboembolism
_xdrug therapy
650 0 4 _aThrombosis
_xcomplications
650 0 4 _aThyroid Diseases
_xcomplications
650 0 4 _aVitamins
_xtherapeutic use
773 0 _tJournal of the Irish Medical Association
_gvol. 62
_gno. 384
_gp. 203-12
999 _c4895197
_d4895197